Tirzepatide activates both GLP-1 and GIP receptors, producing greater average weight loss than GLP-1 alone in clinical trials. Compounded versions contain the same active ingredient as Mounjaro® and Zepbound®.

| Phase | Dose |
|---|---|
| Weeks 1–4 | 2.5 mg once weekly. |
| Weeks 5–8 | 5 mg once weekly. |
| Weeks 9+ | Titrated up to 7.5–15 mg based on tolerance and goals. |
Compounded Tirzepatide starts at $279 / 28-day supply. No insurance required. HSA/FSA eligible.
Prescription required. Our licensed provider determines whether treatment is medically appropriate. Medication and dose are not guaranteed. Prices shown apply to the stated supply period and may vary if the prescribed treatment, pharmacy, or product changes.
In head-to-head trials (SURMOUNT-1 vs STEP-1), tirzepatide 15 mg produced roughly 20–22% average body weight loss vs ~15% for semaglutide 2.4 mg. Individual results vary.
It's a newer, more complex molecule and dual-target formulation.
Complete a 5-minute online intake. A US-licensed physician reviews your history and only prescribes if it's safe and appropriate for you.
Check If I Qualify — Free & Fast